AI-translated archive post

Participation and Presentation at the Re2O Clinical Session at the APS KOREA 2026 International Conference

메리성형외과의원 · 메리성형외과의원 · April 14, 2026

Participation and Presentation at the Re2O Clinical Session at the APS KOREA 2026 International Conference ​ Merry Plastic Surgery participated in the APS KOREA 2026 international...

AI translation notice

This page is an English translation of a Korean Naver Blog archive entry. For exact wording and source context, verify against the Korean archive original and the original Naver post.

Clinic: 메리성형외과의원

Original post date: April 14, 2026

Translated at: April 25, 2026 at 6:03 AM

Medical note: This translation does not guarantee medical accuracy or suitability for treatment decisions.

Participation and Presentation at the Re2O Clinical Session at the APS KOREA 2026 International Conference image 1

Participation and Presentation at the Re2O Clinical Session at the APS KOREA 2026 International Conference image 2

Participation and Presentation at the Re2O Clinical Session at the APS KOREA 2026 International Conference

Merry Plastic Surgery participated in the APS KOREA 2026 international academic event held at the Hotel Seoul Dragon City.

This conference was an international event representing the plastic surgery field in Asia and the Pacific, and it brought together about 1,000 medical professionals from 40 countries to share the latest clinical knowledge and procedure trends.

At this event, Hong Seong-taek, CEO of Merry Plastic Surgery, gave a presentation on the tissue regeneration mechanism and actual clinical applications centered on the human acellular dermal matrix (hADM)-based skin booster, Re2O, under the theme “Versatile Application of phADM (Re2O): From Skin Rejuvenation to Surgical Potential.”

In particular, he shared the scope of Re2O’s applications and treatment outcomes through clinical cases covering a wide range of fields, from skin boosters for skin improvement to scar treatment and tissue regeneration, using hADM-derived extracellular matrix (ECM).

In addition, this conference introduced not only skin regeneration treatment strategies centered on Re2O, but also a treatment approach using the injector “i-ject B,” presenting an integrated procedure direction that can be used in clinical settings.

Merry Plastic Surgery will continue to build more advanced medical technology and safer treatment standards through ongoing academic activities and the sharing of clinical experience.

Continue browsing

Keep exploring this clinic's public source trail

Return to the source archive for more translated posts, or open the Korean clinic profile to compare other public channels.